Federal award
BIOMERIEUX INC
W81K0219F0117
Contract
Obligated and Ceiling
- Obligated (net)
- $80,185.02
- Ceiling (potential value, not spending)
- $80,185.02
- Current value
- $80,185.02
- Gross positive obligations
- $205,379.53
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- COMPAGNIE MERIEUX ALLIANCE · PFPLR7Q9VGC8
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0219F0117
- Parent vehicle (IDV PIID)
- W81K0217D0012
- Award type code
- C
- Actions
- 4 · May 22, 2019 to Sep 28, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 28, 2020 | FY2020 | P00003 | B | −$125,184.19 | — |
| Jun 16, 2020 | FY2020 | P00002 | B | −$10.32 | — |
| Oct 25, 2019 | FY2020 | P00001 | C | $205,379.53 | — |
| May 22, 2019 | FY2019 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.